Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1973-03-26
1978-01-03
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424238, 424241, 424242, A61K 3156, A61K 3157, A61K 3158
Patent
active
040667570
ABSTRACT:
An oral contraceptive regimen in which a progestin is administered from the fifth through the twenty-fifth day of the physiological cycle is described. The amount of progestin administered is serially increased during the period of administration; regular menses occurs when administration of the regimen is complete.
REFERENCES:
patent: 3409721 (1968-11-01), Applezweig
patent: 3568828 (1971-03-01), Lerner
patent: 3639600 (1972-02-01), Hendrix
patent: 3733407 (1973-05-01), Segre
Larsson-Cohn et al., ACTA Endocrinologica 63:705-716, (1970), Effects of Continuous Daily Administration of 0.5mg of Chlormadinone Acetate on the Plasma Levels of Progesterone and on the Urinary Excretion of Luteinizing Hormone and Total Oestrogens.
Larsson-Cohn et al., ACTA Endocrinologica 63:216-224, (1970), Effects of Continuous Daily Administration of 0.5mg of Norethindrone on the Plasma Levels of Progesterone and on the Urinary Excretion of Luteinizing Hormone, Pregnanediol and Total Oestrogens.
Rudel et al., I.E.P.T. Sect. 48, vol. 2, Chap. 34:392-394, 411-415, (1972), Oral Contraceptives Progestogens, Purgamon Press N.Y., N.Y.
Rudel et al., Birth Control Contraception and Abortion: 101-130, (1973), Progestogens, Macmillan Co., N.Y., N.Y.
Lambert Benjamin F.
Ortho Pharmaceutical Corporation
Rose Shep K.
LandOfFree
Oral contraceptive regimen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral contraceptive regimen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral contraceptive regimen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-281483